BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22386132)

  • 1. Magnetic resonance imaging of radial sclerosing lesions (radial scars) of the breast.
    Linda A; Zuiani C; Londero V; Cedolini C; Girometti R; Bazzocchi M
    Eur J Radiol; 2012 Nov; 81(11):3201-7. PubMed ID: 22386132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observer variability and applicability of BI-RADS terminology for breast MR imaging: invasive carcinomas as focal masses.
    Kim SJ; Morris EA; Liberman L; Ballon DJ; La Trenta LR; Hadar O; Abramson A; Dershaw DD
    AJR Am J Roentgenol; 2001 Sep; 177(3):551-7. PubMed ID: 11517046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
    Gökalp G; Topal U
    Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of probably benign breast MRI lesions.
    Eby PR; DeMartini WB; Gutierrez RL; Saini MH; Peacock S; Lehman CD
    AJR Am J Roentgenol; 2009 Sep; 193(3):861-7. PubMed ID: 19696303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement.
    Gutierrez RL; DeMartini WB; Eby PR; Kurland BF; Peacock S; Lehman CD
    AJR Am J Roentgenol; 2009 Oct; 193(4):994-1000. PubMed ID: 19770321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast MRI in the evaluation of locally recurrent or new breast cancer in the postoperative patient: correlation of morphology and enhancement features with the BI-RADS category.
    Seely JM; Nguyen ET; Jaffey J
    Acta Radiol; 2007 Oct; 48(8):838-45. PubMed ID: 17851971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI?
    Linda A; Zuiani C; Furlan A; Lorenzon M; Londero V; Girometti R; Bazzocchi M
    AJR Am J Roentgenol; 2012 Feb; 198(2):272-80. PubMed ID: 22268168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of suspected breast cancer by MRI: a prospective clinical trial using a combined kinetic and morphologic analysis.
    Wiener JI; Schilling KJ; Adami C; Obuchowski NA
    AJR Am J Roentgenol; 2005 Mar; 184(3):878-86. PubMed ID: 15728612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
    Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
    Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study.
    Baltzer PA; Benndorf M; Dietzel M; Gajda M; Runnebaum IB; Kaiser WA
    AJR Am J Roentgenol; 2010 Jun; 194(6):1658-63. PubMed ID: 20489110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted ultrasound of the breast in women with abnormal MRI findings for whom biopsy has been recommended.
    Meissnitzer M; Dershaw DD; Lee CH; Morris EA
    AJR Am J Roentgenol; 2009 Oct; 193(4):1025-9. PubMed ID: 19770325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign (BI-RADS 2) lesions in breast MRI.
    Spick C; Szolar DH; Tillich M; Reittner P; Preidler KW; Baltzer PA
    Clin Radiol; 2015 Apr; 70(4):395-9. PubMed ID: 25649442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer yield of probably benign breast MR examinations.
    Eby PR; Demartini WB; Peacock S; Rosen EL; Lauro B; Lehman CD
    J Magn Reson Imaging; 2007 Oct; 26(4):950-5. PubMed ID: 17896380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound.
    Vassiou K; Kanavou T; Vlychou M; Poultsidi A; Athanasiou E; Arvanitis DL; Fezoulidis IV
    Eur J Radiol; 2009 Apr; 70(1):69-76. PubMed ID: 18295425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can breast MRI computer-aided detection (CAD) improve radiologist accuracy for lesions detected at MRI screening and recommended for biopsy in a high-risk population?
    Arazi-Kleinman T; Causer PA; Jong RA; Hill K; Warner E
    Clin Radiol; 2009 Dec; 64(12):1166-74. PubMed ID: 19913125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of initially only magnetic resonance mammography-detected findings with and without correlate at second-look sonography: distribution according to patient history of breast cancer and lesion size.
    Linda A; Zuiani C; Londero V; Bazzocchi M
    Breast; 2008 Feb; 17(1):51-7. PubMed ID: 17709249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The BI-RADS breast magnetic resonance imaging lexicon.
    Molleran V; Mahoney MC
    Magn Reson Imaging Clin N Am; 2010 May; 18(2):171-85, vii. PubMed ID: 20494304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound.
    Pediconi F; Catalano C; Roselli A; Dominelli V; Cagioli S; Karatasiou A; Pronio A; Kirchin MA; Passariello R
    Invest Radiol; 2009 Jul; 44(7):412-21. PubMed ID: 19448554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of Malignancy and Imaging Characteristics of Probably Benign Lesions Seen at Breast MRI.
    Grimm LJ; Anderson AL; Baker JA; Johnson KS; Walsh R; Yoon SC; Ghate SV
    AJR Am J Roentgenol; 2015 Aug; 205(2):442-7. PubMed ID: 26204298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BI-RADS® 3 lesions at contrast-enhanced breast MRI: is an initial short-interval follow-up necessary?
    Bahrs SD; Baur A; Hattermann V; Hahn M; Vogel U; Claussen CD; Siegmann-Luz KC
    Acta Radiol; 2014 Apr; 55(3):260-5. PubMed ID: 23969262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.